Venture funding remains elusive for Black tech entrepreneurs in the US
Venture capital, from Silicon Valley to New York, remains an industry deeply rooted in its investing and hiring patterns
Venture capital, from Silicon Valley to New York, remains an industry deeply rooted in its investing and hiring patterns
XM Cyber, a breach and attack simulation platform, has closed its Series B round on $17m, as it looks to grow its global sales and marketing efforts.
Laxman Pai, Opalesque Asia: The aggregate value of private equity real estate (PERE) deals in the US fell by 68% in Q2 2020 from the previous quarter - with every sector recording a decline, said
Laxman Pai, Opalesque Asia: U.S. private equity transactions fell nearly 20% in deal value to $326.7 billion on 2,173 deals in the first six months of 2020 from the year-ago period, said a study. According
The European Central Bank is set to meet on Thursday and is widely expected to announce a substantial increase to its Asset Purchase Programme. Antonio Cavarero, head of investment at Generali Investments, expects the ECB
Monday saw a flurry of new high yield financings launched, including one market debut, the €1.25bn buy-out package for BC Partners’ takeover of Italian machinery maker Industria Macchine Automatiche (IMA). Also launched on Monday were
Impala Platinum Holdings, the South African platinum mining company, has launched a tender offer for half its outstanding rand-denominated convertible bonds.
UBS’s head of Asia equity capital markets Peihao Huang has resigned from her position. She will join JP Morgan’s ECM team, GlobalCapital Asia understands.
UBS’s head of Asia equity capital markets Peihao Huang has resigned from her position. She will join JP Morgan’s ECM team, GlobalCapital Asia understands.
UBS’s head of Asia equity capital markets Peihao Huang has resigned from her position. She will join JP Morgan’s ECM team, GlobalCapital Asia understands.
Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.
Harbour Biomed has pocketed HK$1.71bn ($220.8m) by pricing its IPO just above the mid point of the marketed range.
Fitch has downgraded Malaysia for the first time since the Asian financial crisis, slashing the sovereign rating by one notch to BBB+ due to the Covid-19 crisis and political uncertainty.
Vesync, a home appliance retailer, kicked off the roadshow for its up to HK$1.55bn ($200.1m) IPO in Hong Kong on Monday, with the company's growth story during the pandemic expected to appeal to investors.
